Scott Koenig Macrogenics Inc (MGNX) insider trading activity

Scott Koenig is President and CEO of MACROGENICS INC. Currently has a direct ownership of 777,415 shares of MGNX, which is worth approximately $1.91 Million. The most recent transaction as insider was on Feb 15, 2025, when has been sold 42,329 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 777K

Infinity% 3M change

27.86% 12M change

Total Value Held $1.91 Million

Scott Koenig Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 15 2025	BUY Exercise of conversion of derivative security	-	42,329 Added 5.16%	777,415 Common Stock
Feb 08 2025	BUY Grant, award, or other acquisition	-	31,673 Added 4.13%	735,086 Common Stock
Oct 07 2024	SELL Bona fide gift	-	53,265 Reduced 100.0%	0 Common Stock
Sep 23 2024	SELL Bona fide gift	-	374,215 Reduced 34.73%	703,413 Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$249,672 $17.4 p/Share	14,349 Reduced 1.31%	1,077,628 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	-	42,341 Added 3.73%	1,091,977 Common Stock
May 16 2022	BUY Exercise of conversion of derivative security	$80,430 $1.51 p/Share	53,265 Added 4.83%	1,049,636 Common Stock

Also insider at

AGTC

APPLIED GENETIC TECHNOLOGIES CORP Healthcare

Director

GLYC

GLYCOMIMETICS INC Healthcare

Scott Koenig

President and CEO

Alachua, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MGNX shares.

Notify only if

Value

Insider Trading

Get notified when an Macrogenics Inc insider buys or sells MGNX shares.

Notify only if

Operation

Value

Type

News

Receive news related to MACROGENICS INC

Track Activities on MGNX

Account